Neuroimaging Biomarkers
Neuroimaging biomarkers use neuroimaging techniques in order to image the morphology, function, microenvironment, metabolism, or molecular content of the brain and its lesions.
Neuroimaging Biomarkers for Alzheimer's Disease
Neuroimaging in Alzheimer's disease patients includes Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET), Structural, and Functional Magnetic Resonance Imaging (MRI).
Neuroimaging Biomarkers for Multiple Sclerosis
Neuroimaging in Multiple Sclerosis (MS) patients include conventional Magnetic Resonance Imaging (MRI), quantitative neuroimaging biomarkers, and other advanced neuroimaging techniques.
Neuroimaging Biomarkers for Stroke
Neuroimaging in stroke patients include conventional Magnetic Resonance Imaging (MRI) and other advanced neuroimaging techniques.
Neuroimaging Biomarkers for Disorders of Consciousness
Neuroimaging in patients with disorders of conciousness include conventional Magnetic Resonance Imaging (MRI) and other advanced neuroimaging techniques.
Try BrainMagix
Experience the most advanced neuroimaging techniques free for 30 days